Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel
Journal cover image

GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.

Publication ,  Journal Article
Panjwani, N; Mulvihill, EE; Longuet, C; Yusta, B; Campbell, JE; Brown, TJ; Streutker, C; Holland, D; Cao, X; Baggio, LL; Drucker, DJ
Published in: Endocrinology
January 2013

Glucagon-like peptide-1 receptor (GLP-1R) agonists reduce lipid accumulation in peripheral tissues, attenuating atherosclerosis and hepatic steatosis in preclinical studies. We examined whether GLP-1R activation decreases atherosclerosis progression in high-fat diet-fed male ApoE(-/-) mice after administration of streptozotocin and treatment with the long-acting GLP-1R agonist taspoglutide administered once monthly vs. metformin in the drinking water for 12 wk. Taspoglutide did not reduce plaque area or lipid content in the aortic arch or abdominal aorta, and no significant change in aortic macrophage accumulation was detected after taspoglutide or metformin. In contrast, hepatic triglyceride levels were significantly reduced in livers from taspoglutide-treated mice. Both peripheral and intracerebroventricular administration of exendin-4 rapidly decreased plasma triglyceride levels in fasted mice, and taspoglutide therapy in ApoE(-/-) mice modulated the expression of hepatic genes controlling fatty acid uptake and oxidation. We were unable to detect expression of the entire Glp1r coding sequence in macrophages isolated from ApoE(-/-), C57BL/6, and IL10(-/-) mice. Similarly, Glp1r mRNA transcripts were not detected in RNA from isolated murine hepatocytes. Using Western blotting and tissue extracts from Glp1r(+/+) and Glp1r(-/-) mice, and cells transfected with a tagged murine GLP-1R cDNA, we could not validate the sensitivity and specificity of three different GLP-1R antisera commonly used for the detection of GLP-1R protein. Taken together, these findings illustrate divergent actions of GLP-1R agonists on atherosclerosis progression and accumulation of ectopic lipid in ApoE(-/-) mice and highlight the importance of indirect GLP-1R actions for the control of hepatic lipid accumulation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Endocrinology

DOI

EISSN

1945-7170

Publication Date

January 2013

Volume

154

Issue

1

Start / End Page

127 / 139

Location

United States

Related Subject Headings

  • Receptors, Glucagon
  • Peptides
  • Mice, Knockout
  • Mice
  • Male
  • Macrophages
  • Liver
  • Interleukin-10
  • Hepatocytes
  • Glucose Tolerance Test
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Panjwani, N., Mulvihill, E. E., Longuet, C., Yusta, B., Campbell, J. E., Brown, T. J., … Drucker, D. J. (2013). GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology, 154(1), 127–139. https://doi.org/10.1210/en.2012-1937
Panjwani, Naim, Erin E. Mulvihill, Christine Longuet, Bernardo Yusta, Jonathan E. Campbell, Theodore J. Brown, Catherine Streutker, et al. “GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.Endocrinology 154, no. 1 (January 2013): 127–39. https://doi.org/10.1210/en.2012-1937.
Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology. 2013 Jan;154(1):127–39.
Panjwani, Naim, et al. “GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.Endocrinology, vol. 154, no. 1, Jan. 2013, pp. 127–39. Pubmed, doi:10.1210/en.2012-1937.
Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, Drucker DJ. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology. 2013 Jan;154(1):127–139.
Journal cover image

Published In

Endocrinology

DOI

EISSN

1945-7170

Publication Date

January 2013

Volume

154

Issue

1

Start / End Page

127 / 139

Location

United States

Related Subject Headings

  • Receptors, Glucagon
  • Peptides
  • Mice, Knockout
  • Mice
  • Male
  • Macrophages
  • Liver
  • Interleukin-10
  • Hepatocytes
  • Glucose Tolerance Test